-
公开(公告)号:NO20021379A
公开(公告)日:2002-03-20
申请号:NO20021379
申请日:2002-03-20
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , KOCK MICHAEL , HOEGER THOMAS , GRANDEL ROLAND , MUELLER REINHOLD , SCHULT SABINE
IPC: A61K31/5517 , A61P3/10 , A61P9/00 , A61P9/10 , A61P9/14 , A61P11/00 , A61P13/12 , A61P17/02 , A61P19/02 , A61P25/00 , A61P25/08 , A61P25/10 , A61P25/14 , A61P25/16 , A61P25/28 , A61P29/00 , A61P31/04 , A61P35/00 , A61P35/04 , A61P37/02 , A61P43/00 , C07D487/06 , C07D519/00 , C07D487/04
CPC classification number: C07D487/06
-
公开(公告)号:BG105689A
公开(公告)日:2002-02-28
申请号:BG10568901
申请日:2001-07-10
Applicant: BASF AG
Inventor: STEINER GERD , SCHNELLHAAS KURT , LUBISCH WILFRIED , HOLZENKAMP UTA , STARCK DOROTHEA , KNOPP MONIKA , SZABO LASZLO , EMLING FRANZ , GARCIA-LADONA FRANCISCO J , HOFMANN HANS-PETER , UNGER LILIANE
IPC: C07D495/04 , A61K31/505 , A61K31/519 , A61P9/10 , C07D495/14 , A61K31/495 , A61K31/55
Abstract: The invention relates to the utilization of pyrimidine derivatives of formula wherein the substituents have the meaning cited in the description, and to the utilization of the physiologically compatible salts thereof for producing medicaments used for preventing and treating cerebral ischaemia and strokes. 1 claim
-
公开(公告)号:BR0009948A
公开(公告)日:2002-01-08
申请号:BR0009948
申请日:2000-04-11
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , KOCK MICHAEL , HOEGER THOMAS , GRANDEL ROLAND , SCHULT SABINE , MUELLER REINHOLD
IPC: C07D235/08 , A61K31/4184 , A61K31/4427 , A61K31/4523 , A61K31/496 , A61K31/551 , A61P3/10 , A61P9/00 , A61P9/10 , A61P13/12 , A61P19/02 , A61P25/00 , A61P25/08 , A61P25/16 , A61P25/28 , A61P29/00 , A61P31/04 , A61P35/00 , A61P35/04 , A61P43/00 , C07D235/10 , C07D235/12 , C07D235/14 , C07D235/16 , C07D401/08 , C07D403/08 , C07D235/06
Abstract: Compounds of the formula I or IIand their tautomeric forms, possible enantiomeric and diastereomeric forms, possible cistrans isomers on the rings in A and prodrugs thereof, pharmaceutical compositions containing these compounds and methods of treating neurodegenerative diseases or neuronal damage with these compounds.
-
34.
公开(公告)号:BG63388B1
公开(公告)日:2001-12-31
申请号:BG10339999
申请日:1999-05-12
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , MOELLER ACHIM , TREIBER HANS-JOERG
IPC: A61K31/403 , A61K31/4035 , A61K31/405 , A61K31/4439 , A61K31/496 , A61K31/517 , A61K31/519 , A61K31/5377 , A61P9/00 , A61P25/00 , A61P25/08 , A61P25/14 , A61P25/28 , A61P35/00 , A61P35/04 , A61P43/00 , C07D209/48 , C07D209/66 , C07D239/70 , C07D239/96 , C07D401/12 , C07D471/04 , C07D475/02 , A61K31/505 , A61K31/40
Abstract: The compounds are used in medicine. The heterocycle benzamides have the formula where R1, R2, R3, R4, R5, X, m & n have the meanings listed in the description. 17 claims
-
公开(公告)号:BG105550A
公开(公告)日:2001-12-31
申请号:BG10555001
申请日:2001-05-30
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , KOCK MICHAEL , HOEGER THOMAS
IPC: C07D235/18 , A61K20060101 , A61K31/10 , A61K31/404 , A61K31/41 , A61K31/4184 , A61K31/454 , A61P20060101 , A61P3/10 , A61P7/02 , A61P9/00 , A61P13/12 , A61P25/00 , A61P25/08 , A61P25/14 , A61P25/16 , A61P25/28 , A61P29/00 , A61P31/00 , A61P35/00 , A61P35/04 , A61P37/02 , A61P43/00 , C07D20060101 , C07D209/14 , C07D235/04 , A61K31/4189
Abstract: The invention relates to the use of 2-phenyl-benzimidazolesd and 2-phenylindoles of general formula wherein A means N or CH, R1 means hydrogen, branched or unbranched C1-C6 alkyl and a C-atom of the alkyl radical can also carry an OR11 or a group R5, R2 means hydrogen, chlorine, fluorine, bromine iodine, branched and unbranched C1-C6 alkyl, nitro, CF3, CN, NR21R22, NH-CO-R23, OR21, R 3 means (CH2)q-NR31R32 and q can be 0, 1, 2 or 3 and R4 means hydrogen, branched or unbranched C1-C6 alkyl, chlorine, bromine, fluorine, nitro, cyano NR41R42, NH-CO-R43, OR41; as inhibitors of the enzyme poly(ADP-ribose)-polymerase for producing medicaments. 22 claims
-
公开(公告)号:HU0102732A2
公开(公告)日:2001-12-28
申请号:HU0102732
申请日:1999-04-20
Applicant: BASF AG
Inventor: KNOPP MONIKA , LUBISCH WILFRIED , MOELLER ACHIM , TREIBER HANS-JOERG
IPC: C07D295/08 , A61K31/16 , A61K31/166 , A61K31/27 , A61K31/395 , A61K31/40 , A61K31/455 , A61K31/495 , A61K31/535 , A61K31/5375 , A61P9/00 , A61P13/12 , A61P25/00 , A61P25/08 , A61P25/14 , A61P25/28 , A61P27/12 , A61P29/00 , A61P35/00 , A61P35/04 , A61P37/02 , A61P43/00 , C07C229/38 , C07C237/20 , C07C237/22 , C07C237/32 , C07C237/36 , C07D209/14 , C07D213/82 , C07D233/64 , C07D237/32 , C07D237/36 , C07D295/14 , C07D295/155
Abstract: An amide of the formula I and its tautomeric forms, possible enantiomeric and diastereomeric forms, E and Z forms, and possible physiologically tolerated salts, in which the variables have the following meanings: A —(CH2)p—R1, where R1 can be pyrrolidine, morpholine, piperidine, —NR5R6 and and R5, R6 and R7 can, independently of one another, be hydrogen, C1-C4-alkyl, CH2Ph, Ph, CH2CH2Ph, it also being possible for the phenyl rings to be substituted by R6, and p can be 1 and 2, and B can be phenyl, pyridyl, pyrimidyl and pyridazyl, it also being possible for the rings to be substituted by up to 2 R8 radicals, and D can be a bond, —(CH2)m—, —CH═CH—, —C═C—, and R2 is chlorine, bromine, fluorine, C1-C6-alkyl, NHCO—C1-C4-alkyl, NHSO2—C1-C4-alkyl, NO2, —O—C1-C4-alkyl and NH2, and R3 is —C1-C6-alkyl, branched or unbranched, and which may also carry a phenyl ring, indolyl ring or cyclohexyl ring which is in turn substituted by a maximum of two R8 radicals, where R8 is hydrogen, C1-C4-alkyl, branched or unbranched, —O—C1-C4-alkyl, OH, Cl, F, Br, I, CF3, NO2, NH2, CN, COOH, COO—C1-C4-alkyl, NHCO—C1-C4-alkyl, —NHSO2—C1-C4-alkyl and —SO2—C1-C4-alkyl; and Y is phenyl, pyridine, pyrimidine and pyrazine and R4 is hydrogen, COOR9 and CO—Z in which Z is NR10R11 and R9 is hydrogen, C1-C6-alkyl, linear or branched, and which may [lacuna] substituted by a phenyl ring which may itself also be substituted by one or two R12 radicals, and R10 is hydrogen, C1-C6-alkyl, linear or branched, and which may [lacuna] substituted by a phenyl ring which itself may also be substituted by one or two R12 radicals, and R11 is hydrogen, C1-C6-alkyl, branched or unbranched, which may also be and substituted by a phenyl ring which may also carry an R9 radical, and R12 can be hydrogen, C1-C4-alkyl, branched or unbranched, —O—C1-C4-alkyl, OH, Cl, F, Br, J, CF3, NO2, NH2, CN, COOH, COO—C1-C4-alkyl, —NHCO—C1-C4-alkyl, —NHCO-phenyl, —NHSO2—C1-C4-alkyl, NHSO2-phenyl, —SO2—C1-C4-alkyl and —SO2-phenyl, R13 is hydrogen, C1-C6-alkyl, linear or branched, and which may [lacuna] substituted by a phenyl ring which may itself also be substituted by one or two R12 radicals, and R14 is hydrogen, C1-C6-alkyl, linear or branched, and which may [lacuna] substituted by a phenyl ring which may itself also be substituted by one or two R12 radicals, and n is a number 0, 1 or 2, and m,q are, independently of one another, a number 0, 1, 2, 3 or 4.
-
公开(公告)号:SK7142001A3
公开(公告)日:2001-12-03
申请号:SK7142001
申请日:1999-11-23
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , KOCK MICHAEL , HOGER THOMAS , SCHULT SABINE , GRANDEL ROLAND , MULLER REINHOLD
IPC: A61K20060101 , A61K31/4184 , A61K31/454 , A61K31/496 , A61P20060101 , A61P3/12 , A61P9/00 , A61P9/10 , A61P13/12 , A61P17/02 , A61P25/00 , A61P25/08 , A61P25/14 , A61P25/16 , A61P25/28 , A61P29/00 , A61P31/04 , A61P35/00 , A61P43/00 , C07D20060101 , C07D235/30 , C07D401/04 , C07D401/14 , C07D403/04
Abstract: Compounds of the formula Ia or IB where A is a saturated or monounsaturated heterocyclic, 4 - to 8-membered ring which contains one or two nitrogen atoms, and their tautomeric forms, possible enantiomeric and diastereomeric forms, their prodrugs and possible physiologically tolerated salts are useful as inhibitors of the enzyme poly(ADP-ribose)polymerase.
-
38.
公开(公告)号:HU0101688A2
公开(公告)日:2001-11-28
申请号:HU0101688
申请日:1999-04-19
Applicant: BASF AG
Inventor: KNOPP MONIKA , LUBISCH WILFRIED , MOELLER ACHIM , TREIBER HANS-JOERG
IPC: A61K31/4164 , A61K31/426 , A61K31/4427 , A61K31/4439 , A61K31/444 , A61K31/455 , A61K31/4709 , A61K31/4725 , A61K31/4965 , A61K31/505 , A61K31/506 , A61K31/5377 , A61P9/04 , A61P9/08 , A61P9/10 , A61P13/12 , A61P21/00 , A61P25/00 , A61P25/08 , A61P25/28 , A61P27/12 , A61P43/00 , C07D213/81 , C07D213/82 , C07D233/90 , C07D239/28 , C07D239/30 , C07D239/42 , C07D241/28 , C07D277/20 , C07D277/44 , C07D277/56 , C07D401/04 , C07D401/12 , C07D413/12
Abstract: Amides of the general formula Iand their tautomeric and isomeric forms, possible enantiomeric and diastereomeric forms, as well as possible physiologically tolerable salts, in which the variables have the meanings stated in the description, their preparation and use as calpain inhibitors.
-
公开(公告)号:NO20014963L
公开(公告)日:2001-11-13
申请号:NO20014963
申请日:2001-10-12
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , KOCK MICHAEL , HOEGER THOMAS , GRANDEL ROLAND , SCHULT SABINE , MUELLER REINHOLD
IPC: C07D235/08 , A61K31/4184 , A61K31/4427 , A61K31/4523 , A61K31/496 , A61K31/551 , A61P3/10 , A61P9/00 , A61P9/10 , A61P13/12 , A61P19/02 , A61P25/00 , A61P25/08 , A61P25/16 , A61P25/28 , A61P29/00 , A61P31/04 , A61P35/00 , A61P35/04 , A61P43/00 , C07D235/10 , C07D235/12 , C07D235/14 , C07D235/16 , C07D401/08 , C07D403/08 , C07D235/06
Abstract: Compounds of the formula I or IIand their tautomeric forms, possible enantiomeric and diastereomeric forms, possible cistrans isomers on the rings in A and prodrugs thereof, pharmaceutical compositions containing these compounds and methods of treating neurodegenerative diseases or neuronal damage with these compounds.
-
公开(公告)号:DE10021468A1
公开(公告)日:2001-11-08
申请号:DE10021468
申请日:2000-05-04
Applicant: BASF AG
Inventor: KOCK MICHEL , LUBISCH WILFRIED , JENTZSCH AXEL
IPC: A61K8/06 , A61K8/14 , A61K8/49 , A61Q1/02 , A61Q1/04 , A61Q3/00 , A61Q5/00 , A61Q5/06 , A61Q15/00 , A61Q17/04 , A61Q19/00 , A61Q19/10 , A61K7/48 , A61K7/075
Abstract: The invention relates to the use of PARP inhibitors in cosmetic preparations, especially in after-sun lotions. The invention further relates to cosmetic preparations that contain a PARP inhibitor and a UV absorber.
-
-
-
-
-
-
-
-
-